Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey

This study was conducted to evaluate the effect of a clinical pharmacist-led patient education program for type 2 diabetic patients at Isfahan Endocrine & Metabolism Research Center (IEMRC) from April 2008 to January 2009. and occurs mostly in children and young adults. Stuart was observing people on pharmaceutical drugs not getting better, and he was hearing vitamin users talk of their improved health conditions, even as he managed a pharmacy in Austin, Texas. A qualitative study using focus groups was conducted in Sydney, Australia. The live seminar incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community and ambulatory care practice settings. This indicates that, although pharmacists believe that diabetes is a treatable disease, they infrequently provide diabetes patient education. Trials were excluded where the pharmacist was part of a healthcare team.

Express Scripts will establish “quality metrics” it and the other pharmacies should meet when it comes to caring for diabetic patients. These data suggest that pharmacist consultations provided to patients with diabetes can decrease total healthcare costs in a health maintenance organization. Logistic regression models determined characteristics associated with current practice. Optimization of insulin therapy requires careful assessment of multiple patient-specific factors, including nutritional intake, prior insulin requirements, and concomitant medications (5). Approved supplies include blood glucose monitors, test strips, lancets, lancing devices, control solutions, and insulin pumps. Conclusion: Pharmacists with more advanced, experiential-based training and national certification consistently reported providing more activities related to diabetes practice and generally held more positive attitudes toward the disease and its management, compared to other pharmacists. If you or your prescriber have a preference for a particular brand of the drug, your pharmacist can provide you with that brand.

directions for use (58.6 %) and common/important adverse effects (25.7 %)], education on exercise (36.5 %), education on diet (47.7 %), and monitoring medication compliance (27.9 %). Facilitators identified were: being perceived as part of a pharmacist’s role (for all priority services), pharmacies with more than 50 diabetes customers per month (for diet education), and pharmacists’ involvement in diabetes training (for compliance monitoring). The key barrier identified was lower pharmacist availability (for diet education as well as compliance monitoring). After all, it is fully possible to reverse type 2 diabetes with a healthy diet and lifestyle. Many pharmacists believed that they should extend their roles particularly regarding patient education and monitoring. Since this a pragmatic, practice-based trial, the sample size was inflated to 100 to account for possible losses to follow-up. References Centers for Disease Control and Prevention.

Wang H, McEuen M, Mize L, Cisek C. Private sector in Indonesia: a desk review [Internet]. Bethesda: Health Systems 20/20 project Abt Associates Inc.; 2009 [cited 9 Jan 2015]. Kementrian Kesehatan Republik Indonesia (Kemenkes RI). Keputusan Menteri Kesehatan nomor 1027/MENKES/SK/IX/2004: standar layanan kefarmasian di apotek [Ministry of Health Decree number1027/MENKES/SK/IX/2004: standards for pharmaceutical care in community pharmacies]. Jakarta: Kemenkes RI; 2006.

Purwanti A, Harianto, Supardi S. Gambaran pelaksanaan standar pelayanan farmasi di apotek DKI Jakarta [Implementation of the standards for pharmacy services in community pharmacies in Jakarta]. Maj Ilmu Kefarmasian. 2004; 1(2):102–115. Herman M, Sasanti R, Raharni, Siahaan S. Analisis faktor internal dan eksternal yang terkait dengan model pelayanan prima di apotek [Analysis of internal and external factors related to the model of extended services in community pharmacies]. Bul Penelit Sist Kesehat.

Clinical champions are in post for two years during which time we are encouraged to work closely with representatives from Diabetes UK and Novo Nordisk to facilitate our work. The unit of analysis was the physician. Konsensus pengendalian dan pencegahan diabetes mellitus tipe 2 di Indonesia 2011 [The 2011 consensus for the management and prevention of type 2 diabetes mellitus in Indonesia] [Internet]. To address this as a potential reason for lack of continued clinical improvement, we have revised our service protocol to continue following patients at a less frequent (monthly) interval once they have achieved their A1C goal. This plan was executed in a 12-week period, with repeated laboratory tests for basic chemistry and A1C. Analisis pengelompokan dan pemetaan kecamatan sebagai dasar program untuk mengatasi masalah-masalah sosial-ekonomi di Kota Surabaya [Analysis of distric mapping systemto manage socio-economic issues in Surabaya] [dissertation].

Surabaya: Institut Sepuluh Nopember; 2010. Stewart K, O’Shea J, McCaig D. Agreement of practitioners with the recommendations of the ‘Guidelines for community pharmacists on the care of patients with diabetes’. J Soc Admin Pharm. 2003;20(1):13–7. Pemerintah Republik Indonesia. Peta jalan menuju Jaminan Kesehatan Nasional 2012–2019 [A road map to the National Health Insurance 2012–2019] [Internet].

Jakarta: Pemerintah Republik Indonesia; 2012 [cited 10 Feb 2015]. ISBN: 978-602-18863-0-4. Pemerintah Republik Indonesia. Undang-Undang Republik Indonesia nomor 40 tahun 2004: Sistem Jaminan Sosial Nasional [Republic of Indonesia Law number 40 of 2004: National Social Insurance System]. Jakarta: Sekretariat Negara Republik Indonesia; 2004.